{"instruction": "Write a prior authorization medical necessity letter for I-CGM.", "input": {"patient_summary": {"patient_id": "12345", "age": null, "sex": "female", "diagnoses": [{"code_system": "ICD-10", "code": "E11.65", "description": null}], "labs": [{"name": "HbA1c", "value": 9.2, "unit": "%", "collected_date": "2025-09-30"}, {"name": "Fasting glucose", "value": 175.0, "unit": "mg/dL", "collected_date": "2025-10-05"}], "meds": [{"name": "Metformin ER 1000 mg PO BID (active, started 2023-11-10)", "dose": null, "route": null, "frequency": null, "start_date": null, "end_date": null, "status": "active"}, {"name": "Insulin glargine 10 units SC nightly (active, started 2024-07-01)", "dose": null, "route": null, "frequency": null, "start_date": null, "end_date": null, "status": "active"}], "vitals": [{"name": "BP_systolic", "value": 128.0, "unit": "mmHg", "measured_date": null}, {"name": "BP_diastolic", "value": 78.0, "unit": "mmHg", "measured_date": null}, {"name": "Weight", "value": 82.0, "unit": "kg", "measured_date": null}, {"name": "Height", "value": 165.0, "unit": "cm", "measured_date": null}], "note_date": "2025-10-20"}, "policy_passages": [{"text": "Article Title\nBilling and Coding: Implantable Continuous Glucose Monitors (I-CGM)\nArticle Type\nBilling and Coding\nOriginal Effective Date\n11/02/2020\nRevision Effective Date\n10/09/2025\nRevision Ending Date\nN/A\nRetirement Date\nN/A\nCPT codes, descriptions, and other data only are copyright 2024 American Medical Association. All Rights Reserved.\nApplicable FARS/HHSARS apply.\nFee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not\npart of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or\ndispense medical services. The AMA assumes no liability for data contained or not contained herein.\nCurrent Dental Terminology \u00a9 2024 American Dental Association. All rights reserved.\nCopyright \u00a9 2025, the American Hospital Association, Chicago, Illinois. Reproduced with permission. No portion of the AHA\ncopyrighted materials contained within this publication may be copied without the express written consent of the AHA.\nAHA copyrighted materials including the UB\u201004 codes and descriptions may not be removed, copied, or utilized within any\nsoftware, product, service, solution, or derivative work without the written consent of the AHA. If an entity wishes to utilize\nany AHA materials, please contact the AHA at 312\u2010893\u20106816.\nMaking copies or utilizing the content of the UB\u201004 Manual, including the codes and/or descriptions, for internal purposes,\nresale and/or to be used in any product or publication; creating any modified or derivative work of the UB\u201004 Manual and/or\ncodes and descriptions; and/or making any commercial use of UB\u201004 Manual or any portion thereof, including the codes\nand/or descriptions, is only authorized with an express license from the American Hospital Association. The American\nHospital Association (the \"AHA\") has not reviewed, and is not responsible for, the completeness or accuracy of any\ninformation contained in this material, nor was the AHA or any of its affiliates, involved in the preparation of this material,\nor the analysis of information provided in the material. The views and/or positions presented in the material do not\nnecessarily represent the views of the AHA. CMS and its products and services are not endorsed by the AHA or any of its\naffiliates.\nCMS National Coverage Policy\nSocial Security Act (Title XVIII) Standard References:\nT"}, {"text": "Updated On\nEffective Dates\nStatus\n03/27/2025\n04/01/2025 - 10/08/2025\nSuperseded\nView\n12/27/2024\n01/01/2025 - 03/31/2025\nSuperseded\nView\n09/27/2024\n11/04/2024 - 12/31/2024\nSuperseded\nView\n09/14/2024\n11/04/2024 - N/A\nSuperseded\nView\n11/07/2023\n11/16/2023 - 11/03/2024\nSuperseded\nView\nSome older versions have been archived. Please visit the MCD Archive Site  to retrieve\nthem.\nKeywords\nN/A\n10/29/25, 10:21 AM\nArticle - Billing and Coding: Implantable Continuous Glucose Monitors (I-CGM) (A58127)\nhttps://www.cms.gov/medicare-coverage-database/view/article.aspx?articleid=58127&ver=19&keyword=Continuous Glucose Monitor&keywordType=starts&area\u2026\n43/43"}, {"text": "Notice: It is not appropriate to bill Medicare for services that are not covered (as described\nby the entire LCD) as if they are covered. When billing for non-covered services, use the\nappropriate modifier.\nDocumentation Requirements\n1. All documentation must be maintained in the patient's medical record and made\navailable to the contractor upon request.\n2. Every page of the record must be legible and include appropriate patient identification\ninformation (e.g., complete name, dates of service[s]). The documentation must include\nthe legible signature of the physician or non-physician practitioner responsible for and\nproviding the care to the patient.\n3. The submitted medical record must support the use of the selected ICD-10-CM code(s).\nThe submitted CPT/HCPCS code must describe the service performed.\nCoding Information\nCPT/HCPCS Codes\nGroup 1 (3 Codes)\nGroup 1 Paragraph\nNote: Providers are reminded to refer to the long descriptors of the CPT codes in their\nCPT book.\n\n\nGroup 1 Codes\nCode\nDescription\n0446T\nInsj impltbl glucose sensor\n0447T\nRmvl impltbl glucose sensor\n0448T\nRemvl insj impltbl gluc sens\n10/29/25, 10:21 AM\nArticle - Billing and Coding: Implantable Continuous Glucose Monitors (I-CGM) (A58127)\nhttps://www.cms.gov/medicare-coverage-database/view/article.aspx?articleid=58127&ver=19&keyword=Continuous Glucose Monitor&keywordType=starts&areaI\u2026\n4/43"}], "requested_service": "I-CGM"}, "output": "Subject: Prior Authorization Request for Implantable Continuous Glucose Monitor (I-CGM)\n\nPatient: 12345 | Sex: female | Age: None\nDiagnoses: E11.65\nRecent HbA1c: 9.2%\nCurrent Medications: Metformin ER 1000 mg PO BID (active, started 2023-11-10), Insulin glargine 10 units SC nightly (active, started 2024-07-01)\n\nMedical Necessity Rationale:\n- Qualifying diabetes diagnosis with suboptimal control and/or active insulin therapy.\n- Continuous glucose monitoring is medically necessary to improve glycemic management and reduce hypoglycemia risk, consistent with payer policy criteria.\n\nPolicy Citations (source page):\n- /Users/saimudragada/Projects/pa-assistant/data/raw_policies/CGM.pdf (p.2) \u2014 Article Title Billing and Coding: Implantable Continuous Glucose Monitors (I-CGM) Article Type Billing and Coding Original Effective Date 11/02/2020 Revision Effective Date 10/09/2025 Revision Ending Date N/A Retirement Date N/A CPT codes, descriptions, and other data only are copyright 2024 America\u2026\n- /Users/saimudragada/Projects/pa-assistant/data/raw_policies/CGM.pdf (p.43) \u2014 Updated On Effective Dates Status 03/27/2025 04/01/2025 - 10/08/2025 Superseded View 12/27/2024 01/01/2025 - 03/31/2025 Superseded View 09/27/2024 11/04/2024 - 12/31/2024 Superseded View 09/14/2024 11/04/2024 - N/A Superseded View 11/07/2023 11/16/2023 - 11/03/2024 Superseded View Some older version\u2026\n- /Users/saimudragada/Projects/pa-assistant/data/raw_policies/CGM.pdf (p.4) \u2014 Notice: It is not appropriate to bill Medicare for services that are not covered (as described by the entire LCD) as if they are covered. When billing for non-covered services, use the appropriate modifier. Documentation Requirements 1. All documentation must be maintained in the patient's medical r\u2026\n\nSincerely,\nPrior Authorization Assistant"}
